Company attributes
Industry
Location
B2X
Founder
AngelList URL
Pitchbook URL
Founded Date
2011
Wellfound ID
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
The Longevity Fund is a venture capital firm in San Francisco that prefers to invest in companies that focus on extending the period of healthy human life and ameliorate age-related decline in physical function. Founded 2011 by Laura Deming in San Francisco, California, the firm invests in series A, series B, and series C rounds. The notable investment portfolio of The Longevity Fund includes Epirium Bio, eXo Imaging, Fauna Bio, Spring Discovery, System1 Biosciences, Decibel Therapeutics, Precision BioSciences, and UNITY Biotechnology. As of January 2020, The Longevity Fund has made 11 investments and two exits.
Timeline
No Timeline data yet.
Associated Investment Funds
Accelerator Batches
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
